Explore All Access
Check if your research matches the topics covered in Expert Review of Anticancer Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Expert Review of Anticancer Therapy : Impact Factor & More
eISSN: 1744-8328pISSN: 1473-7140
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Expert Review of Anticancer Therapy is a monthly peer-reviewed medical journal covering all clinical aspects of cancer therapy. It was established in 2001 and is published by Taylor & Francis under the academic publishing division of Informa. The current Editor-in-Chief is Gertjan J L Kaspers who is Head of Pediatric Oncology at VU University Medical Center Amsterdam. According to Journal Citation Reports, the journal has a 2019 impact factor of 3.573. Less
Expert Review of Anticancer Therapy Key Metrics
CiteScore 
6.7
Eigenfactor
0.001 - 0.005
H-Index
79
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.08
Time to Accept
4
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months21%
4 to 6 months50%
7 to 9 months22%
Above 9 months7%
Did you find this useful?
Topics Covered on Expert Review of Anticancer Therapy
Cancer
Lung cancer
Breast cancer
Lymph node
Systematic review
Immunotherapy
Chemoradiotherapy
Hepatocellular carcinoma
Neuroendocrine tumors
Toxicity
Epidermal growth factor receptor
Pediatric acute myeloid leukemia
Thyroid cancer
Trastuzumab emtansine
Prostate cancer
Clinical trial
Systemic therapy
Platinum
Tumor microenvironment
Toxicity profile
Expert Review of Anticancer Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Review of Anticancer Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Expert Review of Anticancer Therapy
NRF2/KEAP1 signaling inhibitors in gynecologic cancers
- 9 Dec 2024
- Expert Review of Anticancer Therapy
Radiation-induced nasopharyngeal necrosis combined with local recurrence in nasopharyngeal carcinoma: diagnosis and treatment strategies
- 8 Dec 2024
- Expert Review of Anticancer Therapy
Arguments for and against extending the interval between colonoscopies following negative results in colorectal cancer screening
- 1 Dec 2024
- Expert Review of Anticancer Therapy
Efficacy and safety analysis of vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) in the treatment of osteosarcoma: a systematic review and meta-analysis
- 28 Nov 2024
- Expert Review of Anticancer Therapy
Unlocking survival benefits: primary tumor resection in de novo stage IV breast cancer patients
- 17 Nov 2024
- Expert Review of Anticancer Therapy
Statin use and ovarian cancer outcomes
- 11 Nov 2024
- Expert Review of Anticancer Therapy
NRF2/KEAP1 signaling inhibitors in gynecologic cancers
- 9 Dec 2024
- Expert Review of Anticancer Therapy
Radiation-induced nasopharyngeal necrosis combined with local recurrence in nasopharyngeal carcinoma: diagnosis and treatment strategies
- 8 Dec 2024
- Expert Review of Anticancer Therapy
Arguments for and against extending the interval between colonoscopies following negative results in colorectal cancer screening
- 1 Dec 2024
- Expert Review of Anticancer Therapy
Efficacy and safety analysis of vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) in the treatment of osteosarcoma: a systematic review and meta-analysis
- 28 Nov 2024
- Expert Review of Anticancer Therapy
Unlocking survival benefits: primary tumor resection in de novo stage IV breast cancer patients
- 17 Nov 2024
- Expert Review of Anticancer Therapy
Statin use and ovarian cancer outcomes
- 11 Nov 2024
- Expert Review of Anticancer Therapy
Compare Similar Journals with Expert Review of Anticancer Therapy
Select Journals to Compare with Expert Review of Anticancer Therapy
Total journals - 9
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Oncology
Publisher: ELSEVIER
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
BMC Cancer
Publisher: BMC
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
Oncotarget
Publisher: Impact Journals
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
Expert Review of Anticancer Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Expert Review of Anticancer Therapy
How long has Expert Review of Anticancer Therapy been actively publishing? 
Expert Review of Anticancer Therapy has been in operation since 2000 till date.
What is the publishing frequency of Expert Review of Anticancer Therapy?
Expert Review of Anticancer Therapy published with a Monthly frequency.
How many articles did Expert Review of Anticancer Therapy publish last year?
In 2023, Expert Review of Anticancer Therapy publsihed 121 articles.
What is the eISSN & pISSN for Expert Review of Anticancer Therapy?
For Expert Review of Anticancer Therapy, eISSN is 1744-8328 and pISSN is 1473-7140.
What is Citescore for Expert Review of Anticancer Therapy?
Citescore for Expert Review of Anticancer Therapy is 6.7.
What is the H Index for Expert Review of Anticancer Therapy ?
H Index for Expert Review of Anticancer Therapy is 79.
What is SNIP score for Expert Review of Anticancer Therapy?
SNIP score for Expert Review of Anticancer Therapy is 1.08.
What is the SJR for Expert Review of Anticancer Therapy?
SJR for Expert Review of Anticancer Therapy is Q2.
Who is the publisher of Expert Review of Anticancer Therapy?
TAYLOR & FRANCIS LTD is the publisher of Expert Review of Anticancer Therapy.
